A Fast-Moving Inherited Macular Dystrophy
An embankment that has quietly weakened along one stretch for years rarely gives any warning before it fails — the day it finally gives way, water doesn't trickle through, it floods in within hours. Something comparable happens behind the retina with Sorsby fundus dystrophy: a defective protein makes Bruch's membrane thicken in a way it shouldn't, prompting the retina to force fresh blood vessels through that weakened point — vessels that are structurally unsound from the start and begin leaking almost as soon as they form. It's this early, out-of-place vessel growth — appearing decades before it normally would in age-related eye disease — that places Sorsby dystrophy among the more aggressive conditions we manage.
When a patient in Pakistan, typically in their thirties or forties, experiences central vision loss that unfolds across weeks rather than years, that speed alone is frequently the first clue pointing toward Sorsby rather than a milder, more ordinary dystrophy.
The defining trait of this disease is honestly just its speed. One eye can lose meaningful central vision within a matter of weeks; the other typically follows, sometimes years afterward. Patients describe straight lines that suddenly look bent, a blur spreading fast across the centre of their vision, and occasionally an odd struggle seeing in dim rooms that showed up quietly, well before anything more dramatic followed.
TIMP3 is the gene responsible, and under normal conditions it keeps tissue turnover around Bruch's membrane properly balanced. Once that balance fails, the membrane thickens where it shouldn't, and the retina reacts by forcing new vessels through the weakened spot — vessels that are fragile from the moment they form and start leaking almost immediately. A single faulty copy of TIMP3 from either parent is all it takes to set the whole process in motion.
A scatter of pale, yellow-white spots along the retinal vessels is typically the first thing an examiner notices during a routine fundus check. Attention then shifts to confirming active new vessel growth specifically — OCT angiography is usually sufficient, with fluorescein angiography reserved for cases needing a sharper look, since leaking vessels change how urgently things need to move. A TIMP3 genetic test confirms the cause, and given the pace this condition can take, that result is treated as urgent rather than routine.
If active leaking vessels are found, addressing them comes first, ahead of everything else in the plan. Once the eye stabilises, patients who qualify move into regenerative stem cell therapy aimed at supporting the retina going forward, and because Sorsby tends to move quickly, follow-up visits happen more often here than they would for a slower-moving dystrophy.
It absolutely can be, and that unusually fast pace is one of the very clues that points specifically toward Sorsby dystrophy. Almost every other inherited macular condition takes years rather than weeks to unfold, which is exactly why this particular speed stands out so clearly.
That kind of confusion isn't rare, given that both conditions can produce similar-looking leaking vessels on a scan. What genuinely separates the two is when it started, whether a family history is present, and a TIMP3 genetic test confirming the underlying cause.
We treat it as urgent, since leaking vessels left unchecked can cost additional vision within a short window. Bringing that particular issue under control always takes priority over everything else in the plan.
Not for certain — though the risk deserves serious attention, since this is a dominant condition, giving each child of an affected parent close to a fifty percent chance of carrying the faulty gene. Severity varies quite a bit from person to person, and genetic testing can offer your family a clearer picture of where things stand.